The REVEAL® Registry is the largest and most ambitious research effort ever undertaken to study patients with pulmonary arterial hypertension (PAH). REVEAL is the only national registry study of its kind, and is designed to bridge the gap between science and practice by characterizing the current management and clinical features of patients with PAH. We believe it will be a tremendous resource in providing valuable information that will help shape the PAH community.

REVEAL is a multicenter, observational, U.S.-based registry study of pulmonary arterial hypertension. A planned 3500 patients will be enrolled by december 2009 and will be followed for at least 5 years. | Learn More